Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
International Journal of Pharmaceutics: X|October 23, 2025
pH-responsive polymeric nanoparticles for peptide delivery: Synergistic STING pathway activation enhances tumor immunotherapyMengjie Rui, Haidan Tang, Lianglai Gao, et al.Journal of Cellular and Molecular Medicine|June 29, 2021
Ring finger protein 19A is overexpressed in non-small cell lung cancer and mediates p53 ubiquitin-degradation to promote cancer growthYu Cheng, Yujiao Hu, Huanxi Wang, et al.Bioorganic & Medicinal Chemistry Letters|March 11, 2026
Design, synthesis, and biological evaluation of pyridine-triazole derivatives as URAT1 inhibitors with potential application in hyperuricemia and goutYujiao Hu, Wei Liu, Ruikang Sun, et al.Frontiers in Cellular and Infection Microbiology|May 1, 2026
Machine learning models based on laboratory data: new insight into the differential diagnosis of tuberculous and viral meningitisXiaoyan Hao, Yujiao Hu, Lei Zhou, et al.Frontiers in Cellular and Infection Microbiology|June 4, 2026
Simultaneous molecular detection of <i>Mycobacterium tuberculosis</i> and multidrug resistance using CRISPR-AaCas12b-based nucleic acid assayYujiao Hu, Dan Zhao, Yanjun Diao, et al.Journal of Medicinal Chemistry|May 22, 2024
Discovery of Novel p53-MDM2 Inhibitor (RG7388)-Conjugated Platinum<sup>IV</sup> Complexes as Potent Antitumor AgentsWei Liu, Yi Ma, Youyou He, et al.Cancer Science|March 23, 2021
MZT2A promotes NSCLC viability and invasion by increasing Akt phosphorylation via the MOZART2 domainHuanxi Wang, Xizi Jiang, Yu Cheng, et al.Experimental Cell Research|January 24, 2021
PCGF3 promotes the proliferation and migration of non-small cell lung cancer cells via the PI3K/AKT signaling pathwayYujiao Hu, Yu Cheng, Xizi Jiang, et al.Frontiers in Immunology|July 1, 2026
Multi-center validation of a machine learning model for early detection of monoclonal immunoglobulin-related disorders using routine laboratory dataYujiao Hu, Xiaoyan Hao, Xiaoyan Li, et al.Journal of Cancer|January 4, 2021
Silencing of CASC8 inhibits non-small cell lung cancer cells function and promotes sensitivity to osimertinib via FOXM1Xizi Jiang, Jingqian Guan, Yitong Xu, et al.Pageof 3